Literature DB >> 11430578

Involvement of the rat caudate nucleus in the immunostimulatory effect of DAGO.

L V Devoino1, M A Cheido, E L Al'perina.   

Abstract

The involvement of the caudate nucleus, i.e., the terminal zone of the nigrostriatal dopaminergic system, in neuroimmunostimulation during the activation of mu opioid receptors by the highly specific agonist DAGO. Single doses of DAGO (100 microg/kg) in sham-operated control Wistar rats induced significant increases in the numbers of direct IgM-antibody-forming and total rosette-forming cells at the peak of the immune response after immunization with sheet red blood cells. The experiments showed that bilateral electrolytic lesioning of the caudate nucleus in rats suppressed the immune response, demonstrating its involvement in neuroimmunomodulation. Since the effect of immunostimulation induced by DAGO disappeared when given to animals with caudate nucleus lesions, it was concluded that this structure is involved in activatory immunogenesis via mu opioid mechanisms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11430578     DOI: 10.1023/a:1010394820455

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  28 in total

1.  Involvement of cholinergic neurons in the release of dopamine elicited by stimulation of mu-opioid receptors in striatum.

Authors:  N Dourmap; E Clero; J Costentin
Journal:  Brain Res       Date:  1997-02-28       Impact factor: 3.252

2.  In vivo occupancy of D2 dopamine receptors by nafadotride.

Authors:  B Levant; N R Vansell
Journal:  Neuropsychopharmacology       Date:  1997-08       Impact factor: 7.853

3.  A light and electron microscopical study of enkephalin-immunoreactive structures in the rat neostriatum after removal of the nigrostriatal dopaminergic pathway.

Authors:  C A Ingham; S H Hood; G W Arbuthnott
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

4.  A method of increased sensitivity for detecting single antibody-forming cells.

Authors:  A J Cunningham
Journal:  Nature       Date:  1965-09-04       Impact factor: 49.962

5.  Conditioned immunomodulation: investigations of the role of endogenous activity at mu, kappa, and delta opioid receptor subtypes.

Authors:  L Perez; D T Lysle
Journal:  J Neuroimmunol       Date:  1997-11       Impact factor: 3.478

6.  Involvement of brain dopaminergic structures in neuroimmunomodulation.

Authors:  L Devoino; E Alperina; O Galkina; R Ilyutchenok
Journal:  Int J Neurosci       Date:  1997-10       Impact factor: 2.292

7.  Cellular basis for interactions between catecholaminergic afferents and neurons containing Leu-enkephalin-like immunoreactivity in rat caudate-putamen nuclei.

Authors:  V M Pickel; J Chan; S R Sesack
Journal:  J Neurosci Res       Date:  1992-02       Impact factor: 4.164

8.  Opposing activities of brain opioid receptors in the regulation of humoral and cell-mediated immune responses in the rat.

Authors:  J Radulović; B D Janković
Journal:  Brain Res       Date:  1994-10-24       Impact factor: 3.252

Review 9.  Pharmacological studies on the interrelation between the dopaminergic, GABAergic and opioid peptidergic systems in the central nervous system of the rat.

Authors:  K Kamata
Journal:  Jpn J Pharmacol       Date:  1987-12

10.  Analogues of beta-LPH61-64 possessing selective agonist activity at mu-opiate receptors.

Authors:  B K Handa; A C Land; J A Lord; B A Morgan; M J Rance; C F Smith
Journal:  Eur J Pharmacol       Date:  1981-04-09       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.